Delivery Order SPE2DB22D2211-SPE2DB25FSEQM
- Not listed
- The Defense Logistics Agency awarded a $1,930.67 delivery order to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count) on July 30, 2025, with completion scheduled for July 31, 2025. This firm fixed price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,914.33 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract. The award, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction and is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) under a firm fixed-price contract valued at $12,323.76. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a non-competitive delivery order placed against the contractor's existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count) under a firm fixed-price contract valued at $11,829.94, with an ultimate completion date of August 21, 2025. This non-set-aside competitive award represents a child contract issued against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of KERENDIA 10 MG TABLET 30S. The contract has a ceiling value of $5,107.73 and a period of performance through June 6, 2025. AmerisourceBergen Drug Corp is a for-profit organization headquartered in Conshohocken, Pennsylvania that is a critical supplier of medical and pharmaceutical products to federal agencies, including...
- The Defense Logistics Agency awarded a delivery order valued at $24,071.89 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units). This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a non-competitive set-aside transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count) on September 8, 2025, with a ceiling value of $3,447.42 and an ultimate completion date of September 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $3,984.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). The contract, which is not set-aside and was competitively awarded, is scheduled for completion by August 11, 2025, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEQMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,215.81 to AmerisourceBergen Drug Corp for KERENDIA 10 mg tablets (30-count supply) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026. The pharmaceutical supply will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical vendor in the federal medical supply chain, particularly supporting military and veteran healthcare systems. This delivery order is representative of the company's extensive portfolio of pharmaceutical products supplied to the Defense Health Agency and other federal healthcare entities under the DLA Troop Support Medical contract vehicle. The SPE2DX IDC functions as a comprehensive global pharmaceutical support mechanism, enabling AmerisourceBergen to deliver brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/10/25 |